Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J Crook

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
International Journal of Clinical Practice|May 7, 2014
An observational study of patient satisfaction with fesoterodine in the treatment of overactive bladder: effects of additional educational materialT Schneider, D Arumi, T J Crook, et al.
The Journal of Urology|June 17, 2008
A randomized controlled trial of nephrostomy placement versus tubeless percutaneous nephrolithotomyT J Crook, C R Lockyer, S R Keoghane, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
Antisense targeting of delta opioid receptors in NG 108-15 cells: direct correlation between oligodeoxynucleotide uptake and receptor densityJ Lai, T J Crook, A Payne, et al.
Journal of Pediatric Urology|October 25, 2008
Femoral nerve neuropathy following the psoas hitch procedureT J Crook, H A Steinbrecher, S Tekgul, et al.
BJU International|November 9, 2000
A model of superficial bladder cancer using fluorescent tumour cells in an organ-culture systemT J Crook, I S Hall, L Z Solomon, et al.
Urological Research|April 11, 2002
The effects of meglumine gamma linolenic acid (MeGLA) on an organ culture model of superficial bladder cancerT J Crook, J P Dyer, R I McCormick, et al.
Pediatric Surgery International|May 3, 2005
The effect of short-chain fatty acids butyrate, propionate, and acetate on urothelial cell kinetics in vitro: potential therapy in augmentation cystoplastyJ P Dyer, J M Featherstone, L Z Solomon, et al.
European Urology|July 18, 2002
Intravesical meglumine gamma-linolenic acid in superficial bladder cancer: an efficacy studyN M Harris, T J Crook, J P Dyer, et al.
International Journal of Clinical Practice|June 6, 2014
Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ERS A Kaplan, L Cardozo, S Herschorn, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Development of delta-opioid receptor subtypes and the regulatory role of weaning: radioligand binding, autoradiography and in situ hybridization studiesI Kitchen, F M Leslie, M Kelly, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Clinical Practice|May 7, 2014
An observational study of patient satisfaction with fesoterodine in the treatment of overactive bladder: effects of additional educational materialT Schneider, D Arumi, T J Crook, et al.
The Journal of Urology|June 17, 2008
A randomized controlled trial of nephrostomy placement versus tubeless percutaneous nephrolithotomyT J Crook, C R Lockyer, S R Keoghane, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
Antisense targeting of delta opioid receptors in NG 108-15 cells: direct correlation between oligodeoxynucleotide uptake and receptor densityJ Lai, T J Crook, A Payne, et al.
Journal of Pediatric Urology|October 25, 2008
Femoral nerve neuropathy following the psoas hitch procedureT J Crook, H A Steinbrecher, S Tekgul, et al.
BJU International|November 9, 2000
A model of superficial bladder cancer using fluorescent tumour cells in an organ-culture systemT J Crook, I S Hall, L Z Solomon, et al.
Urological Research|April 11, 2002
The effects of meglumine gamma linolenic acid (MeGLA) on an organ culture model of superficial bladder cancerT J Crook, J P Dyer, R I McCormick, et al.
Pediatric Surgery International|May 3, 2005
The effect of short-chain fatty acids butyrate, propionate, and acetate on urothelial cell kinetics in vitro: potential therapy in augmentation cystoplastyJ P Dyer, J M Featherstone, L Z Solomon, et al.
European Urology|July 18, 2002
Intravesical meglumine gamma-linolenic acid in superficial bladder cancer: an efficacy studyN M Harris, T J Crook, J P Dyer, et al.
International Journal of Clinical Practice|June 6, 2014
Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ERS A Kaplan, L Cardozo, S Herschorn, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Development of delta-opioid receptor subtypes and the regulatory role of weaning: radioligand binding, autoradiography and in situ hybridization studiesI Kitchen, F M Leslie, M Kelly, et al.
Pageof 3